EDWIN AVBUERE: Open Payments
NPI 1013019470 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 39 payments from 16 companies in 2025. Trend: 2023 $1,228 · 2024 $773 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $113 |
| Novo Nordisk Inc | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Corcept Therapeutics | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| SHIELD THERAPEUTICS INC | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
Products named: MOUNJARO, AIRSUPRA, JARDIANCE, Korlym, Kerendia, ACCRUFER, CAPLYTA, Wegovy.
Industry payments across NC — which companies pay providers there.
